RECRUITING

Airway Data Collection With the Entarik Feeding Tube System

Conditions

Healthy Feeding Tube feeding tube placement safety feeding tube placement

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is to evaluate the airway detection performance of the Entarik Feeding Tube System, and to collect data when the Entarik Feeding Tube is in the Airway for device development.

Official Title

Airway Data Collection With the Entarik Feeding Tube System

Quick Facts

Study Start:2025-02-13

Study Completion:2025-12-12

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:RECRUITING

Study ID

NCT06760572

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years

Sexes Eligible for Study:ALL

Accepts Healthy Volunteers:Yes

Standard Ages:ADULT, OLDER_ADULT

Inclusion Criteria	Exclusion Criteria
1. At least 18 years old. 2. Able to provide informed consent. 3. Adults scheduled to undergo a bronchoscopy procedure who will be intubated as part of the standard of care.	1. Known major upper airway malformation. 2. Presence of clinically significant respiratory infection. 3. Known bleeding disorder. 4. Currently pregnant. 5. Current basilar skull fracture. 6. Known sensitivities or allergies to the feeding tube components. 7. Deemed unsuitable for enrollment in study by the investigator based on subject's history (e.g., active anticoagulation therapy) or physical examination.

Inclusion Criteria

Exclusion Criteria

1. At least 18 years old.
2. Able to provide informed consent.
3. Adults scheduled to undergo a bronchoscopy procedure who will be intubated as part of the standard of care.

1. Known major upper airway malformation.
2. Presence of clinically significant respiratory infection.
3. Known bleeding disorder.
4. Currently pregnant.
5. Current basilar skull fracture.
6. Known sensitivities or allergies to the feeding tube components.
7. Deemed unsuitable for enrollment in study by the investigator based on subject's history (e.g., active anticoagulation therapy) or physical examination.

Contacts and Locations

Study Contact

Aaron Miller

CONTACT

415-926-8616

clinicalstudy@theranova.com

Principal Investigator

Daniel Burnett, MD

STUDY_DIRECTOR

Theranova, LLC

Study Locations (Sites)

Temple University Hospital

Philadelphia, Pennsylvania, 19140

United States

Collaborators and Investigators

Sponsor: Theranova, L.L.C.

Daniel Burnett, MD, STUDY_DIRECTOR, Theranova, LLC

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-02-13

Study Completion Date2025-12-12

Study Record Updates

Study Start Date2025-02-13

Study Completion Date2025-12-12

Terms related to this study

Keywords Provided by Researchers

Feeding Tube
feeding tube placement safety
feeding tube placement

Additional Relevant MeSH Terms

Healthy